Mark D. Hines provides research and market analysis to the Left Brain Capital Appreciation Fund. The Fund is managed by Left Brain Wealth Management, a registered investment advisory firm that is owned and operated by Mr. Hines’ classmate from graduate school at the University of Chicago, Noland Langford. Mr. Hines is also a duly registered investment advisor representative with Left Brain Wealth Management. More information regarding the fund is available at Left Brain Capital Management.


To request more information, please use the following form...

Name *
Name
Phone
Phone
Investable Assets *

News and Updates:

June 2018

ValueWalk's Hidden Value Stocks - Left Brain Capital

An in-depth profile on Left Brain Capital Management, chronicling its outperformance in 2016, investment process and some favorite stocks for 2018.

June 6, 2018

ValueWalk - The Under The Radar Hedge Fund Crushing The Market With its Tech Picks

Left Brain Capital Management's stellar lifetime performance - 256.6% since inception - and the investment thinking behind it is the subject of this feature.

February 2018

Black Enterprise - Invest in These 5 Stocks Now, Says Top African-American Investment Manager

Business leaders and entrepreneurs with ideas on where to invest over the next few years.

August 8, 2017

CNBC - Left Brain CEO: Valeant Earnings A ‘Turnaround Story’

Left Brain’s analysis on why Valeant bonds continue to look like a viable option for investors.

August 8, 2017

Barron's - Valeant Bonds Rise on Early Debt Repayment

Why Left Brain sees continued upside in Valeant bonds because of their spreads versus U.S. Treasuries.

July 11, 2017

CityWire Americas - Chicago hedge fund sets up Miami office for LatAm push

Citywire Americas highlights Left Brain’s expansion and its strategic focus on the Caribbean.

April 26, 2017

Hedge Fund Alert - Left Brain Leverages Early Returns

A profile of Left Brain’s stellar performance in 2016 and growth plans for 2017.

March 23, 2017

Barron's - A Safer Way to Invest in Valeant. Really.

How Left Brain is betting on select healthcare companies by buying the bonds, not the stocks.

January 25, 2017

HFM Week- Investors Need to Stop Focusing Solely on Larger Managers

“Do the due diligence and protect yourselves from riskier investments, but stop turning allocation into an asset-sized beauty pageant.” (Subscription required)

December 30, 2016

Barron's - Scientific Games: Stock is Expensive, But Bonds Yield 11%

Left Brain’s latest capital appreciation finds: “[We]… started buying bonds when they were in the $60-$65 range…they have climbed to $83.5.”

December 7, 2016

TheStreet - American Airlines, Health Equity Likely to Keep Rallying Through 2017

Why some of Left Brain’s favorite stocks could grow in value over the next few years.

December 6, 2016

TheStreet - Five Below, Freeport McMorAn Will Fare Well in 2017

“We’ve still got a long way to go…and I think the shares are just getting going.”

November 11, 2016

ThinkAdvisor - The Alternatives to Chasing Yield

How the relentless chase for yield can backfire and why a fresh approach to asset allocation is in order.

November 2, 2016

Opalesque - For This Long-Biased Hedge Fund Manager, Flexibility Is Key

A profile of the Left Brain Capital Appreciation fund, taking a closer look at the fund’s unique approach to asset selection. (Subscription required)

September 30, 2016

Barron's - 4 Energy Bonds that Look Better than the Stocks

“[With these bonds] you don’t have to take a ton of risk and you can get a double-digit return.”

September 1, 2016

InvestmentNews - Are Junk Bonds Becoming The New Equities?

Left Brain’s view on why select high-yield bonds can provide equity-like growth, even as interest rates rise.

Member Login
Welcome, (First Name)!

Forgot? Show
Log In
Enter Member Area
My Profile Log Out